New drug shows promise in preventing migraines
"Millions of people are set to benefit from the first new migraine drug in 20 years," reports the Mail Online.
New research found the injectable drug erenumab cut the number of days people had migraines from an average of 8 a month to between 4 and 5 a month.
Millions of people in the UK get migraines. Symptoms include severe headache, dizziness, nausea, and aversion to light.
Migraine-specific drugs include a group of drugs called triptans, which are used to try to ease the symptoms of attack once it starts, and several drugs that are used to try to prevent attacks.Read Full Article